Daniel B Chastain, Patrick J Tu, Marisa Brizzi, Chelsea A Keedy, Aubrey N Baker, Brittany T Jackson, Amber F Ladak, Leslie A Hamilton, Nicholas R Sells, Andrés F Henao-Martínez, Kathleen A McManus, David B Cluck
People with human immunodeficiency virus (HIV) have a 50% excess risk for intensive care unit (ICU) admission, often for non-HIV-related conditions. Despite this, clear guidance for managing antiretroviral therapy (ART) in this setting is lacking. Selecting appropriate ART in the ICU is complex due to drug interactions, absorption issues, and dosing adjustments. Continuing ART in the ICU can be challenging due to organ dysfunction, drug interactions, and formulary limitations. However, with careful consideration, continuation is often feasible through dose adjustments or alternative administration methods...
May 2024: Open Forum Infectious Diseases